Eureka: World’s First Vaccine and Cure For Cancer Developed by Israeli Medicine Company

The BIG NEWS of a Cancer Curing Drug is coming in from Israel.

An Israeli company has come up with a vaccine against cancer that is both safe in terms of no side-effects and can be administered as a drug. Vaxil BioTherapeutics has developed a vaccine that is now undergoing clinical trials and not yet available in the market. It is being tested at Hadassah University Medical Center in Jerusalem and the trials could take as long as six years to conclude.

A vaccine that is also a drug


The vaccine also acts like a drug, i.e. it can be administered to a sick person as a cure. The vaccine is being tested against a form of blood cancer called multiple myeloma and it is generating enough success. Vaxil says that it could be used against other types of cancer as well, including the common prostrate and breast cancer. The primary immune technology, called VaxHit, can then be developed for other forms of cancer.

How the drug works


The problem with cancer is that the immune system of the body doesn’t know what exactly it should do. The Vaxil product, called ImMucin, trainsthe immune system to act in a specific way. Cancer cells have a marker called MUC1 that is unique to cancer cells only. ImMucin trains T-cellsof our immune system to attack only those cells that are marked by the MUC1 marker. The success rate of the vaccine has not been revealed, but it is supposedly phenomenal. The diversification of the vaccine stems from the fact that MUC1 marks more than 90% of the different cancer cells. Furthermore, since only those cells marked with MUC1 are targeted, the drug has no side-effects and is completely safe to use.

This may be the ultimate magic bullet that scientists have been working towards for a long time. However, there are still a few clinical tests to go.